drugset / Trial / NCT01055366

ELAZOP Switching Study in Korea

NCT01055366

Phase 4 Completed 96 enrolled Alcon Research
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of switching to ELAZOP from prior pharmacotherapy in patients with open-angled glaucoma.

Timeline

Start
2010-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule Topical
Subject Timolol Other / unclassified Topical

Indications